It was reported here in March 2017 that BioTime, Inc. is conducting a Phase I/IIa clinical trial for OpRegen® for treatment of dry AMD. OpRegen is a retinal pigment epithelium (RPE) stem cell transplant therapy currently in development for the treatment of dry age-related macular degeneration (AMD) with geographic atrophy (GA). RPE cells are essential […]
by Dan Roberts January, 2003 (Updated September, 2004) Scientists are researching a new method of retinal transplantation in the continuing effort to restore sight to the blind. Drs. Robert Aramant and Magdalene Seiler (Doheny Eye Institute, Los Angeles) have had preliminary success transplanting double layers of cells from the retinas of aborted fetuses. The two […]
by Dan Roberts November 2001 An online publication of the December 2001 publication of Nature Neuroscience has reported that, with genetic manipulation, cells from the iris may be able to replace photoreceptor cells in the retina. In recent experiments, Dr. Masatoshi Haruta of Kyoto University and colleagues took iris cells from rat eyes, then introduced […]